Verrica Pharmaceuticals Inc. (VRCA) Free cash flow 2018–2025
Verrica Pharmaceuticals Inc. (VRCA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$17.6MFY2025 · since FY2018: -$18.6M → -$17.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.6M | +71.1% |
| FY2024 | -$61.0M | -56.5% |
| FY2023 | -$38.9M | -105.5% |
| FY2022 | -$19.0M | +33.4% |
| FY2021 | -$28.5M | +10.1% |
| FY2020 | -$31.7M | -12.8% |
| FY2019 | -$28.1M | -50.6% |
| FY2018 | -$18.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice